Covered recipient · General Payments record
CHENGQUN SHAO
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$2,946.26
- Reported across 130 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $532.48 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DEXCOM, INC. | $360.69 | 15 |
| Xeris Pharmaceuticals, Inc. | $82.66 | 4 |
| UCB, Inc. | $21.80 | 1 |
| Genentech USA, Inc. | $19.98 | 1 |
| Lilly USA, LLC | $19.20 | 1 |
| Novo Nordisk AS | $14.45 | 1 |
| Abbott Laboratories | $13.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $13.70 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125001614 | CMS |
| Dexcom, Inc. | $27.62 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153291371 | CMS |
| Dexcom, Inc. | $37.01 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153291373 | CMS |
| Dexcom, Inc. | $26.16 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153291375 | CMS |
| Dexcom, Inc. | $6.00 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153291377 | CMS |
| Dexcom, Inc. | $7.16 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153291379 | CMS |
| Dexcom, Inc. | $15.94 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153291381 | CMS |
| Dexcom, Inc. | $17.87 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153291383 | CMS |
| Dexcom, Inc. | $28.80 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153291385 | CMS |
| Dexcom, Inc. | $34.63 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153291387 | CMS |
| Dexcom, Inc. | $10.65 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153291389 | CMS |
| Dexcom, Inc. | $36.11 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153291391 | CMS |
| Dexcom, Inc. | $21.80 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153291393 | CMS |
| Dexcom, Inc. | $17.93 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153291395 | CMS |
| Dexcom, Inc. | $40.61 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153291399 | CMS |
| Dexcom, Inc. | $32.40 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153291397 | CMS |
| Genentech USA, Inc. | $19.98 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132987423 | CMS |
| Lilly USA, LLC | $19.20 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136096988 | CMS |
| Novo Nordisk Inc | $14.45 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096931377 | CMS |
| UCB, Inc. | $21.80 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143135690 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.28 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144590230 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.97 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144590232 | CMS |
| Xeris Pharmaceuticals, Inc. | $14.62 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144590234 | CMS |
| Xeris Pharmaceuticals, Inc. | $18.79 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144590236 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.